Investigating the Mechanisms behind the Positive Food Effect of Abiraterone Acetate: In Vitro and Rat In Situ Studies

The anticancer agent abiraterone suffers from an extensive positive food effect after oral intake of the prodrug abiraterone acetate (Zytiga). The underlying processes determining postprandial abiraterone absorption were investigated in this study. The impact of lipids and lipid digestion products o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marlies Braeckmans (Autor), Patrick Augustijns (Autor), Raf Mols (Autor), Cécile Servais (Autor), Joachim Brouwers (Autor)
Formato: Libro
Publicado: MDPI AG, 2022-04-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5ebac72322a24ee6b411e78f3dbfc1f4
042 |a dc 
100 1 0 |a Marlies Braeckmans  |e author 
700 1 0 |a Patrick Augustijns  |e author 
700 1 0 |a Raf Mols  |e author 
700 1 0 |a Cécile Servais  |e author 
700 1 0 |a Joachim Brouwers  |e author 
245 0 0 |a Investigating the Mechanisms behind the Positive Food Effect of Abiraterone Acetate: In Vitro and Rat In Situ Studies 
260 |b MDPI AG,   |c 2022-04-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14050952 
500 |a 1999-4923 
520 |a The anticancer agent abiraterone suffers from an extensive positive food effect after oral intake of the prodrug abiraterone acetate (Zytiga). The underlying processes determining postprandial abiraterone absorption were investigated in this study. The impact of lipids and lipid digestion products on (i) the solubility of abiraterone acetate and abiraterone, (ii) the conversion of abiraterone acetate to abiraterone, and (iii) the passive permeation of abiraterone was determined in vitro. The interaction of abiraterone acetate and abiraterone with vesicles and colloidal structures in the simulated fed state media containing undigested lipids and lipid digestion products enhanced the solubility of both compounds but limited the esterase-mediated hydrolysis of abiraterone acetate and the potential of abiraterone to permeate. Rat in situ intestinal perfusion experiments with a suspension of abiraterone acetate in static fed state simulated media identified abiraterone concentrations in the perfusate as the main driving force for absorption. However, experiments with ongoing lipolysis in the perfusate highlighted the importance of including lipid digestion as a dynamic process when studying postprandial abiraterone absorption. Future research may employ the in situ perfusion model to study postprandial drug absorption from a dynamic lipolysis-mediated intestinal environment to provide reference data for the optimisation of relevant in vitro models to evaluate food effects. 
546 |a EN 
690 |a abiraterone acetate 
690 |a solubility 
690 |a permeability 
690 |a AMI-system 
690 |a rat in situ intestinal perfusion 
690 |a food effect 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 5, p 952 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/5/952 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/5ebac72322a24ee6b411e78f3dbfc1f4  |z Connect to this object online.